In the Wednesday afternoon session entitled Past, Present, and Future of Gene Therapy: From Vectors and Transgenes to Outcomes, Alfonso Iorio discusses different efficacy and safety outcome measurements, particularly in the context of the coreHEM definition of the core outcome set for gene therapy in hemophilia.
0 Comments